Literature DB >> 28444361

Time for an immunisation paradigm shift.

D N Durrheim1, J L Goodson2.   

Abstract

Keywords:  Eradication; Immunisation; Measles; Microarray patch; Rubella; Syringes; Vaccination

Mesh：

Substances：

Year:  2017        PMID： 28444361     DOI： 10.1093/trstmh/trx018

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  6 in total

1.  A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.

Authors:  Jessica C Joyce; Timothy D Carroll; Marcus L Collins; Min-Hsin Chen; Linda Fritts; Joseph C Dutra; Tracy L Rourke; James L Goodson; Michael B McChesney; Mark R Prausnitz; Paul A Rota
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

2.  Thermostability of Measles and Rubella Vaccines in a Microneedle Patch.

Authors:  Jessica C Joyce; Marcus L Collins; Paul A Rota; Mark R Prausnitz
Journal:  Adv Ther (Weinh)       Date:  2021-07-28

3.  Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.

Authors:  Gavin B Grant; Balcha G Masresha; William J Moss; Mick N Mulders; Paul A Rota; Saad B Omer; Abigail Shefer; Jennifer L Kriss; Matt Hanson; David N Durrheim; Robert Linkins; James L Goodson
Journal:  Vaccine       Date:  2019-03-20       Impact factor: 3.641

4.  Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.

Authors:  Alexandria D Tricoche; Abram L Wagner; Angel Balmaseda; Nery Sanchez; Mayuri Patel; Roger Lopez; Amy Schiller; Sergio Ojeda; Aaron M Frutos; Guillermina Kuan; Aubree Gordon
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

Review 5.  A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.

Authors:  Mark R Prausnitz; James L Goodson; Paul A Rota; Walter A Orenstein
Journal:  Curr Opin Virol       Date:  2020-07-01       Impact factor: 7.090

6.  Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination.

Authors:  James L Goodson; Paul A Rota
Journal:  Drug Deliv Transl Res       Date:  2022-02-24       Impact factor: 5.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.